Kancelaria Patentowa Rejmansp. z o.o.

Legal activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2019-03-05
Share capital
10,000.00 PLN
Registered address
ul. Ciepła 15/41, 50-524 Wrocław, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 5 financial statements were filed late (the longest delay 534 days for 2023). 1 of 5 audited by a statutory auditor.

  • 2025not filed
  • 202431/12/2025
  • 202331/12/2025
  • 202231/12/2023
  • 202130/09/2022
  • 202030/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 796.10kMedianUSD 130.97kAverageUSD 980.71k
Net profit
This companyUSD 154.59kMedianUSD 14.04kAverageUSD 206.35k
Operating costs
This companyUSD 600.56kMedianUSD 88.58kAverageUSD 710.31k
Assets
This companyUSD 764.79kMedianUSD 91.12kAverageUSD 662.80k

Industry

Offer

  • Patent protection
  • Trademark protection
  • Patent consultancy

Authorized Representatives

Joanna Ślęczka – Vice President of the Management Board
Małgorzata Rejman – Vice President of the Management Board
Tadeusz Zbigniew Rejman – President of the Management Board

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

OwnerSharesShare valueStake
Małgorzata Rejmanage 51
33$891.4133%
Tadeusz Zbigniew Rejmanage 84
34$918.4234%
Joanna Ślęczkaage 56
33$891.4133%

Tadeusz Zbigniew Rejman and Małgorzata Rejman hold a combined 67% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2019-04-02.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$299
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$45

FAQ

Last updated: 2026-04-11